Grand Pharmaceutical Group Balance Sheet Health
Financial Health criteria checks 6/6
Grand Pharmaceutical Group has a total shareholder equity of HK$15.3B and total debt of HK$3.3B, which brings its debt-to-equity ratio to 21.7%. Its total assets and total liabilities are HK$22.5B and HK$7.2B respectively. Grand Pharmaceutical Group's EBIT is HK$2.9B making its interest coverage ratio 14.5. It has cash and short-term investments of HK$3.3B.
Key information
21.7%
Debt to equity ratio
HK$3.31b
Debt
Interest coverage ratio | 14.5x |
Cash | HK$3.32b |
Equity | HK$15.27b |
Total liabilities | HK$7.24b |
Total assets | HK$22.52b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 512's short term assets (HK$7.0B) exceed its short term liabilities (HK$5.7B).
Long Term Liabilities: 512's short term assets (HK$7.0B) exceed its long term liabilities (HK$1.5B).
Debt to Equity History and Analysis
Debt Level: 512 has more cash than its total debt.
Reducing Debt: 512's debt to equity ratio has reduced from 34.6% to 21.7% over the past 5 years.
Debt Coverage: 512's debt is well covered by operating cash flow (73.3%).
Interest Coverage: 512's interest payments on its debt are well covered by EBIT (14.5x coverage).